Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) EPS (Weighted Average and Diluted) (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with $0.02 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 166.67% to $0.02 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.18, a 38.46% decrease, with the full-year FY2024 number at -$0.13, up 56.67% from a year prior.
  • EPS (Weighted Average and Diluted) was $0.02 for Q3 2025 at KORU Medical Systems, up from -$0.0 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.04 in Q1 2024 to a low of -$0.23 in Q4 2024.
  • A 5-year average of -$0.04 and a median of -$0.03 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 400.0% in 2021, then skyrocketed 180.0% in 2024.
  • KORU Medical Systems' EPS (Weighted Average and Diluted) stood at -$0.02 in 2021, then tumbled by 100.0% to -$0.04 in 2022, then plummeted by 300.0% to -$0.16 in 2023, then crashed by 43.75% to -$0.23 in 2024, then soared by 108.7% to $0.02 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's EPS (Weighted Average and Diluted) are $0.02 (Q3 2025), -$0.0 (Q2 2025), and $0.03 (Q1 2025).